{"id":"https://openalex.org/W2963347187","doi":"https://doi.org/10.1093/jac/dkz273","title":"Assessing the lymphoid tissue bioavailability of antiretrovirals in human primary lymphoid endothelial cells and in mice","display_name":"Assessing the lymphoid tissue bioavailability of antiretrovirals in human primary lymphoid endothelial cells and in mice","publication_year":2019,"publication_date":"2019-06-05","ids":{"openalex":"https://openalex.org/W2963347187","doi":"https://doi.org/10.1093/jac/dkz273","mag":"2963347187","pmid":"https://pubmed.ncbi.nlm.nih.gov/31335938","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6753470"},"language":"en","primary_location":{"id":"doi:10.1093/jac/dkz273","doi":"https://doi.org/10.1093/jac/dkz273","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jac/dkz273","pdf_url":"https://academic.oup.com/jac/article-pdf/74/10/2974/30039425/dkz273.pdf","source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/jac/article-pdf/74/10/2974/30039425/dkz273.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014699972","display_name":"Shetty Ravi Dyavar","orcid":"https://orcid.org/0000-0002-2141-7214","observed_orcids":["https://orcid.org/0000-0002-2141-7214"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Shetty Ravi Dyavar","raw_affiliation_strings":["Antiviral Pharmacology Laboratory, University of Nebraska Medical Center (UNMC) Center for Drug Discovery, UNMC, Omaha, NE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antiviral Pharmacology Laboratory, University of Nebraska Medical Center (UNMC) Center for Drug Discovery, UNMC, Omaha, NE, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035613509","display_name":"Nagsen Gautam","orcid":"https://orcid.org/0000-0001-5876-6760","observed_orcids":["https://orcid.org/0000-0001-5876-6760"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nagsen Gautam","raw_affiliation_strings":["Department of Pharmaceutical Sciences, College of Pharmacy, UNMC, Omaha, NE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, College of Pharmacy, UNMC, Omaha, NE, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000852039","display_name":"Anthony T. Podany","orcid":"https://orcid.org/0000-0002-8371-0379","observed_orcids":["https://orcid.org/0000-0002-8371-0379"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony T Podany","raw_affiliation_strings":["Antiviral Pharmacology Laboratory, University of Nebraska Medical Center (UNMC) Center for Drug Discovery, UNMC, Omaha, NE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antiviral Pharmacology Laboratory, University of Nebraska Medical Center (UNMC) Center for Drug Discovery, UNMC, Omaha, NE, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029625221","display_name":"Lee C. Winchester","orcid":"https://orcid.org/0000-0002-6118-024X","observed_orcids":["https://orcid.org/0000-0002-6118-024X"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lee C Winchester","raw_affiliation_strings":["Antiviral Pharmacology Laboratory, University of Nebraska Medical Center (UNMC) Center for Drug Discovery, UNMC, Omaha, NE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antiviral Pharmacology Laboratory, University of Nebraska Medical Center (UNMC) Center for Drug Discovery, UNMC, Omaha, NE, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006074466","display_name":"Jonathan A. Weinhold","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan A Weinhold","raw_affiliation_strings":["Antiviral Pharmacology Laboratory, University of Nebraska Medical Center (UNMC) Center for Drug Discovery, UNMC, Omaha, NE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antiviral Pharmacology Laboratory, University of Nebraska Medical Center (UNMC) Center for Drug Discovery, UNMC, Omaha, NE, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031056065","display_name":"Timothy M. Mykris","orcid":"https://orcid.org/0000-0002-0959-6563","observed_orcids":["https://orcid.org/0000-0002-0959-6563"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy M Mykris","raw_affiliation_strings":["Antiviral Pharmacology Laboratory, University of Nebraska Medical Center (UNMC) Center for Drug Discovery, UNMC, Omaha, NE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antiviral Pharmacology Laboratory, University of Nebraska Medical Center (UNMC) Center for Drug Discovery, UNMC, Omaha, NE, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004012100","display_name":"Kayla M. Campbell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kayla M Campbell","raw_affiliation_strings":["Antiviral Pharmacology Laboratory, University of Nebraska Medical Center (UNMC) Center for Drug Discovery, UNMC, Omaha, NE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antiviral Pharmacology Laboratory, University of Nebraska Medical Center (UNMC) Center for Drug Discovery, UNMC, Omaha, NE, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021809794","display_name":"Yazen Alnouti","orcid":"https://orcid.org/0000-0002-3995-3242","observed_orcids":["https://orcid.org/0000-0002-3995-3242"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yazen Alnouti","raw_affiliation_strings":["Department of Pharmaceutical Sciences, College of Pharmacy, UNMC, Omaha, NE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, College of Pharmacy, UNMC, Omaha, NE, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017051528","display_name":"Courtney Vail Fletcher","orcid":"https://orcid.org/0000-0002-3703-7849","observed_orcids":["https://orcid.org/0000-0002-3703-7849"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Courtney V Fletcher","raw_affiliation_strings":["Antiviral Pharmacology Laboratory, University of Nebraska Medical Center (UNMC) Center for Drug Discovery, UNMC, Omaha, NE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antiviral Pharmacology Laboratory, University of Nebraska Medical Center (UNMC) Center for Drug Discovery, UNMC, Omaha, NE, USA","institution_ids":["https://openalex.org/I59130452"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5014699972"],"corresponding_institution_ids":["https://openalex.org/I59130452"],"apc_list":{"value":2869,"currency":"GBP","value_usd":3784},"apc_paid":null,"fwci":3.4482,"has_fulltext":true,"cited_by_count":31,"citation_normalized_percentile":{"value":0.92897764,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":90,"max":99},"biblio":{"volume":"74","issue":"10","first_page":"2974","last_page":"2978"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.92330002784729,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.92330002784729,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.025299999862909317,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.02319999970495701,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antiretroviral-drugs","display_name":"antiretroviral drugs","score":0.9580000042915344},{"id":"https://openalex.org/keywords/hiv-reservoir","display_name":"HIV reservoir","score":0.8240000009536743},{"id":"https://openalex.org/keywords/lymph-nodes","display_name":"lymph nodes","score":0.6990000009536743},{"id":"https://openalex.org/keywords/gut-associated-lymphoid-tissue","display_name":"gut-associated lymphoid tissue","score":0.996999979019165},{"id":"https://openalex.org/keywords/in-vitro-in-vivo-correlation","display_name":"in vitro-in vivo correlation","score":0.7289999723434448},{"id":"https://openalex.org/keywords/efavirenz","display_name":"efavirenz","score":0.8619999885559082},{"id":"https://openalex.org/keywords/dolutegravir","display_name":"dolutegravir","score":1.0},{"id":"https://openalex.org/keywords/emtricitabine","display_name":"emtricitabine","score":0.996999979019165},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.5910000205039978},{"id":"https://openalex.org/keywords/cobicistat","display_name":"cobicistat","score":0.7680000066757202},{"id":"https://openalex.org/keywords/hiv-treatment","display_name":"HIV treatment","score":0.41600000858306885},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.4399999976158142}],"concepts":[{"id":"https://openalex.org/C2779778239","wikidata":"https://www.wikidata.org/wiki/Q422604","display_name":"Emtricitabine","level":5,"score":0.8424082398414612},{"id":"https://openalex.org/C2779182219","wikidata":"https://www.wikidata.org/wiki/Q3765251","display_name":"Darunavir","level":5,"score":0.8264040946960449},{"id":"https://openalex.org/C2779502633","wikidata":"https://www.wikidata.org/wiki/Q937224","display_name":"Dolutegravir","level":5,"score":0.811184823513031},{"id":"https://openalex.org/C2780524789","wikidata":"https://www.wikidata.org/wiki/Q5138908","display_name":"Cobicistat","level":5,"score":0.7312447428703308},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.7186794281005859},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7000752687454224},{"id":"https://openalex.org/C2778414717","wikidata":"https://www.wikidata.org/wiki/Q423467","display_name":"Atazanavir","level":5,"score":0.6962254643440247},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.6836579442024231},{"id":"https://openalex.org/C2780404665","wikidata":"https://www.wikidata.org/wiki/Q421552","display_name":"Raltegravir","level":5,"score":0.6759935617446899},{"id":"https://openalex.org/C2778723075","wikidata":"https://www.wikidata.org/wiki/Q421547","display_name":"Rilpivirine","level":5,"score":0.5149108171463013},{"id":"https://openalex.org/C2779465607","wikidata":"https://www.wikidata.org/wiki/Q304330","display_name":"Abacavir","level":5,"score":0.49770477414131165},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.49731042981147766},{"id":"https://openalex.org/C2778899366","wikidata":"https://www.wikidata.org/wiki/Q421369","display_name":"Maraviroc","level":3,"score":0.4674663841724396},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.44740134477615356},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.4285743534564972},{"id":"https://openalex.org/C2778335254","wikidata":"https://www.wikidata.org/wiki/Q5137314","display_name":"Cmin","level":4,"score":0.41913869976997375},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40746602416038513},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3345790505409241},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3240475654602051},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.29463082551956177},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.20352894067764282},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.09175810217857361},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.07547783851623535},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008221","descriptor_name":"Lymphoid Tissue","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D042783","descriptor_name":"Endothelial Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1093/jac/dkz273","doi":"https://doi.org/10.1093/jac/dkz273","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jac/dkz273","pdf_url":"https://academic.oup.com/jac/article-pdf/74/10/2974/30039425/dkz273.pdf","source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6753470","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6753470","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Antimicrob Chemother","raw_type":"Text"},{"id":"pmid:31335938","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31335938","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antimicrobial chemotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1093/jac/dkz273","doi":"https://doi.org/10.1093/jac/dkz273","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jac/dkz273","pdf_url":"https://academic.oup.com/jac/article-pdf/74/10/2974/30039425/dkz273.pdf","source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8100000023841858,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7614759772","display_name":"The Lymphoid Tissue Pharmacology of Antiretroviral Drugs","funder_award_id":"R01AI124965","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2963347187.pdf","grobid_xml":"https://content.openalex.org/works/W2963347187.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1963812842","https://openalex.org/W1969274526","https://openalex.org/W1969819920","https://openalex.org/W2064140898","https://openalex.org/W2095973346","https://openalex.org/W2098128259","https://openalex.org/W2099724461","https://openalex.org/W2113497618","https://openalex.org/W2117691576","https://openalex.org/W2151219710","https://openalex.org/W2151513445","https://openalex.org/W2155109292","https://openalex.org/W2158520397","https://openalex.org/W2204416339","https://openalex.org/W2263584512","https://openalex.org/W2734753117","https://openalex.org/W2784305126","https://openalex.org/W2797381598","https://openalex.org/W2804971974"],"related_works":["https://openalex.org/W2954992878","https://openalex.org/W3185060353","https://openalex.org/W3041642485","https://openalex.org/W6887860574","https://openalex.org/W6887884414","https://openalex.org/W4206166381","https://openalex.org/W4361283146","https://openalex.org/W2980262515","https://openalex.org/W4401237455","https://openalex.org/W2617283416"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,104,134,179],"secondary":[2],"lymphoid":[3,11,50],"tissues":[4,192],"(LTs),":[5],"lymph":[6],"nodes":[7],"(LNs)":[8],"and":[9,54,99,115,139,155,165,167,175,184,190,226],"gut-associated":[10],"tissue":[12],"(GALT)":[13],"are":[14],"considered":[15],"reservoirs":[16],"for":[17,131],"HIV.":[18],"Antiretrovirals":[19],"(ARVs)":[20],"have":[21,34],"lower":[22],"penetration":[23,33,202],"into":[24],"LT.":[25],"In":[26],"vitro":[27,43,138],"models":[28],"predictive":[29],"of":[30,45,107,136,181,193,206,211,223],"ARV":[31,67,142],"LT":[32,46,105,210],"not":[35],"been":[36],"established.":[37],"OBJECTIVES:":[38],"To":[39],"develop":[40],"an":[41],"in":[42,59,64,69,80,122,137,140,187,209,230],"model":[44],"bioavailability":[47,68,119,143,186],"using":[48],"human":[49],"endothelial":[51],"cells":[52],"(HLECs)":[53],"investigate":[55],"its":[56,227],"predictability":[57,229],"with":[58,215],"vivo":[60,141],"pharmacokinetic":[61],"(PK)":[62],"studies":[63,205],"mice.":[65],"METHODS:":[66],"HLECs":[70],"was":[71,120,144],"evaluated":[72],"at":[73],"the":[74,100],"maximum":[75],"plasma":[76],"concentration":[77],"(Cmax)":[78],"observed":[79],"HIV-infected":[81],"patients.":[82],"ARVs":[83,147,198,208],"were:":[84],"abacavir,":[85],"atazanavir,":[86,171],"darunavir,":[87,172],"dolutegravir,":[88],"efavirenz,":[89,153,182],"elvitegravir,":[90],"emtricitabine,":[91],"maraviroc,":[92],"raltegravir,":[93,173],"rilpivirine,":[94,152],"ritonavir,":[95,160],"tenofovir":[96,161],"disoproxil":[97,162],"fumarate":[98],"PK":[101,106,204],"booster":[102],"cobicistat.":[103],"representative":[108,207],"drugs":[109],"showing":[110],"high":[111,149],"(efavirenz),":[112],"intermediate":[113,157],"(dolutegravir)":[114],"low":[116,168],"(emtricitabine)":[117],"HLEC":[118,177,201,216],"investigated":[121],"BALB/c":[123],"mice":[124,194,212],"given":[125],"50/10/30":[126],"mg/kg":[127],"efavirenz/dolutegravir/emtricitabine":[128],"orally,":[129],"daily":[130],"3":[132],"days.":[133],"concordance":[135],"examined.":[145],"RESULTS:":[146],"showed":[148],"(>67th":[150],"percentile;":[151,159,170],"elvitegravir":[154],"cobicistat),":[156],"(67th-33rd":[158],"fumarate,":[163],"dolutegravir":[164,183],"maraviroc)":[166],"(<33rd":[169],"emtricitabine":[174,185],"abacavir)":[176],"bioavailability.":[178,217],"hierarchy":[180],"LN,":[188],"gut":[189],"brain":[191],"was:":[195],"efavirenz>dolutegravir>emtricitabine.":[196],"CONCLUSIONS:":[197],"displayed":[199],"distinct":[200],"patterns.":[203],"were":[213],"concordant":[214],"These":[218],"findings":[219],"support":[220],"further":[221],"development":[222],"this":[224],"approach":[225],"translational":[228],"humans.":[231]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-07-30T00:00:00"}